tykhr
sign in
free sign up
Acumen Pharmaceuticals Inc
Biotechnology
Healthcare
ABOS
60.08 M shares
NASDAQ US
traded
25 Feb 2025
listed
no
open
1.37
52 week high
4.10
high
1.39
52 week low
1.33
low
1.31
growth
-68.84 %
previous Close
1.39
P/E ratio
market cap
111 M
div yield
0
usd
Sep 2024
qoq
revenue
0.00 %
net incoming
-29.77 M
-44.93 %
eps
0.00 %
-45.71 %
eps surprise
-37.61 %
net profit margin
-2976500000.00 %
0.00 %
operating incoming
-32.27 M
-32.34 %
net change in cash
-34.54 M
-264.26 %
cash on hand
33.18 M
-51.17 %
cost of revenue
0.00 %
top